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Abstract.
The effects of hypothalamic peptides [vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI), growth hormone (GH)-releasing hormone (GHRH) and somatostatin (SRIF) on GH release from cultured bovine adenohypophysial cells were studied. The cells were incubated for 2 h with the peptides after preincubation for 3.5 days. At doses from 10.9 to 10-'M VIP, the amount of GH released was significantly greater than in the controls (P<0.05 to P<0.001). PHI (10-10 to 10-' M) did not alter the bovine GH concentration in the media. Incubation with the media containing 10-' M GHRH, 10-' M VIP, and combined treatment with the VIP plus GHRH increased GH by 186, 40 and 182%, respectively (P<0.001). Furthermore, although VIP-induced GH release was significantly decreased by SRIF compared with the treatment with VIP alone (P<0.001), the VIP significantly blunted the inhibitory effect of the SRIF on GH release by 24% when compared with that of the SRIF plus GHRH without the VIP (P<0.05). GH release in combined treatments with VIP, GHRH and SRIF was significantly less than that of the VIP plus GHRH (P<0.001), but it was a significant 29% increase compared with the SRIF plus GHRH (P<0.05).
The combined effects of the VIP (10-' M) with GHRH (10-', 10.8 and 10-10 M) significantly induced GH release compared with the controls (P<0.001), but no additive effect was not observed when compared with the GHRH alone. The results indicate that VIP, but not PHI, acts directly on cultured adenohypophysial cells to induce GH release in cattle. [4] . PHIlike immunoreactivity is also present in the hypophysial portal plasma in rats [5] . It has been reported that VIP stimulates GH release, both in vivo and in vitro, in rats [6] , acromegalic patients [7, 8] and in vitro in the goat [9] . VIP was reported to stimulate GH release in ovariectomized rats but the effect only occurred when VIP was injected into the third ventricle, suggesting a hypothalamic site of action [10] . An in vitro study has shown that VIP reduces the inhibitory action of somatostatin (SRIF) on GH secretion from rat hemipituitaries [11] . GH responses to VIP and PHI were observed from aggregated rat pituitary cells in culture only et al.
after treatment with dexamethasone [12] . Rivier et al. failed to observe GH releasing activity of VIP, PHI or glucagon on rat pituitary cells [13] . In cows, earlier studies demonstrated that VIP exerts a direct action on perifused adenohypophysial tissues to induce GH release, and that the effect of VIP is less potent than that of GHRH [14, 15] Bovine GH concentrations in media were measured by a validated RIA method previously described by Johke [17] . The GH standard preparation and hormone for iodination were USDA bGH-Bl [19, 20] . The least detectable value was 1.5 ng/ml. The intra-and inter-assay coefficients of variation were 6.0% and 13.0%, respectively.
Peptides

Materials and Methods
The GHRH (hpGRF(1-29)-NH2) and PHI-27 used in this study were prepared by Dr. S. Ohashi of the National Institute of Bioscience and Human Technology, Tsukuba, Japan. Vasoactive intestinal peptide (VIP) and somatostatin (SRIF) were purchased from Peptide Institute Inc. (Osaka, Japan).
Statistical analysis
All data are shown as the mean ± SEM. The statistical significance of differences in GH concentrations was determined by Student's t-test after Bartlett's test for uniformity of the variances [18] . The data for each experiment are the GH concentrations in media from one experiment using two anterior hypophyses.
Results
Animals
Adenohypophyses
were obtained from 8 Holstein steers (17-18 months of age) at a local slaughterhouse and were transported to the laboratory in Krebs-Ringer bicarbonate solution to which were added 1.8 mg glucose/ml, 0.5 mg bacitracin/ml,1.0 mg bovine serum albumin/ml, 0.1 mg streptomycin/ml and 100 IU penicillin/ml (modified KRB solution) at 5 °C within 2 h.
Preparation and culture of adenohypophysial cells
Adenohypophysial cells were enzymatically dispersed by a method previously described by Vale et al. [16] and modified in our laboratory [19, 20] . The cells (5 x 104 cells/ml) resuspended in Dulbecco's modified Eagle's medium (DMEM) [20] were plated in Costar 24-well dishes and maintained at 37 °C in a humidified atmosphere of 5% CO2. The media were changed 2 days after plating. After
Effects of VIP and PHI on GH release from cultured adenohypophysial cells
As shown in Fig. 1 , VIP increased bovine GH concentrations siginificantly in cultured media after 2 h of incubation at doses of 10-9,10.8 and 10-' M (P<0.05 to P<0.001) compared with the controls. VIP at dose of 10-10, however, failed to induced any changes in the GH concentration in media. The GH concentrations after treatments with 10-9. 10-8 and 10-~ M VIP were 11.75 ± 0.45, 12.20 ± 0.77 and 15.75 ± 0.60 ng/ml, respectively, and the amount of GH released by the 10-~ M VIP was significantly (P<0.01 and P<0.001) greater than those released by the 10.9 and 10.8 M VIP. Conversely, PHI (10-10 to 10-' M) had no effect on bovine GH release from cultured pituitary cells after 2 h of incubation when compared with the controls (Fig. 2) . The experiment on the effect of PHI on GH release was repeated once and similar results were obtained.
Combined effects of VIP, GHRH and SRIF on GH release from cultured adenohypophysial cells
As shown in Fig. 3 , GHRH (10-' M), VIP (10-' M) and combined treatment with VIP plus GHRH (10-' M) induced significant increases in the GH concentration in media compared with the controls (P<0.001). The amounts of GH release induced by either GHRH alone (29.2 ± 1.4 ng/ml) or VIP plus GHRH (28.1 ± 1.1 ng/ml) were significantly greater than that induced by VIP alone (14.1 ± 0.7 ng/ml, P<0.001). The combined treatments with GHRH and VIP with SRIF are also shown in Effect of PHI on GH release from bovine adenohypophysial cells in vitro. Each bar represents the mean of 9 to 10 determinations ± SEM from two bovine anterior hypophyses. The GH concentrations in media which resulted from treatments with PHI (10-10 to 10-' M) were compared with the untreated controls. 
Discussion
Earlier studies have demonstrated that VIP (10_6-10-8 M) stimulated GH release from perifused anterior pituitary tissues in cows [14, 15] and goats [9] . In the present study we have shown that VIP is able to induce the release of GH by acting directly on the cultured adenohypophysial cells in steers, and that the VIP-stimulated bovine GH release could be seen at doses as low as 10-9 M. As far as we know, a direct action of VIP on GH release from cultured adenohypophysial cells has not yet been reported in cattle. A mechanism for a direct action of the VIP on pituitary function was suggested since the hypothalamus-neurohypophysis releases VIP into the portal system in rats [4] . Intraventricular injection of VIP also increased GH secretion in rats, indicating a possible hypothalamic site of action [10] . VIP has been reported to stimulate GH release, both in vivo and in vitro in rats [6] . In humans, VIP-stimulated GH release from GHsecreting pituitary tumor cells has been observed only in acromegalic patients [7, S] . In contrast to the results obtained with VIP, PHI failed to alter GH secretion from cultured adenohypophysial cells in the present study. The results were in agreement with previous reports on in vitro studies on rats [13] . PHI is reported, however, to induce GH release from aggregated rat pituitary cells in culture only after treatment with dexamethasone [12] .
As regards the higher potency in GHRH-stimulated bovine GH release than that obtained with VIP, the present study coincided with reports of previous studies on superfused rat pituitary reaggregated cells [12] , and on perifused bovine anterior pituitary tissues [15] . It has been reported that the GH releasing effects of GHRH were maintained longer than that of VIP, suggesting that the somatotrophs might be stimulated to release GH for hours by a short period of GHRH action [15] . It is also known that the half-life of VIP, as determined in the circulation, is approximately 3 min [2] . Recently, we have reported that the bovine GH releasing activity of GHRH could be seen at doses as low as 1013 M [19] .
In order to clarify the role of VIP in modulating bovine GH release from cultured adenohypophysial cells, we have examined the effects of VIP with GHRH and SRIF. In this study we confirmed our previous observation [20] that GHRH and SRIF in- teract to regulate GH secretion in cattle. Furthermore, although the increase in VIP-induced bovine GH was blunted by SRIF, VIP significantly reduced the SRIF induced suppression of GH release. These observations suggested a physiological role of VIP in modulating bovine GH release in vitro at the pituitary level in the presence of both GHRH and SRIF. In this regard, a study on rat hemipituitaries has indicated that VIP can modulate GH secretion via a direct interaction with SRIF inhibitory action at the pituitary level [11] . VIP also reduces the inhibition of rat GH secretion elicited by SRIF [22] . In goats, the relatively lower GH secretory response to VIP applied to the hypothalamus-pituitary tissues suggests that the perifused caprine hypothalamus may release an inhibitory factor, such as SRIF in vitro [9] .
In the present study, the combined effect of VIP and GHRH induced an increase in bovine GH in vitro, but this effect was not additive at all doses of GHRH.
This observation suggests that additive effects of these peptides on GH release could not be expected when two different activators of adenylate cyclase are present simultaneously. GHRH and VIP are known to exert their actions through the activation of CAMP [2, 21] , whereas SRIF may exert its effects on GH secretion by interfering with cAMP production or by an action on the secretory process subsequent to CAMP production in rats [23] . It has also been reported that VIP directly stimulates somatotrophs and that the effect seems to imply a coupling of VIP receptors with cAMP production in rats [6] , and the SRIF-induced inhibition of VIP-stimulated GH release from rat pituitary tumor cells is closely coupled to the inhibition of VIP-stimulated CAMP accumulation [27] . Since amino acid sequences are considerably overlapped between VIP and GHRH [1] , VIP may exhibit 'GRF-like' activity under physiological condition [11] . Kashio et al. [24] have shown that the responses of rat somatomammotrophs to GHRH, SRIF, TRH and VIP appear to be regulated by a common mechanism.
On the other hand, Abribat et al. [25] have reported that not VIP, PHI, secretin or SRIF could displace [125I-Tyr10]hGRF(1-44)-NH2 binding sites in the pituitary of rats at a concentration of 2.4 ,uM, whereas rat hypothalamic GRF was demonstrated to interact with the VIP receptors in the pancreas [26] . It remains to be determined whether the GH releasing mechanism of VIP is related to that of GHRH and SRIF in domestic animals or not.
In conclusion, the present study revealed that VIP, but not PHI, acts directly on cultured adenohypophysial cells to induce bovine GH release. Furthermore, VIP could be involved in the modulation of GH secretion by interaction with the effect of SRIF in vitro.
